Skip to main content
OpenTrials
Completed

NCT Number: NCT02586779

Effectiveness of WhatsApp (a Messenger Program) Usage in Emergency Department (ED)

Effective communication between consulting physicians and the emergency physicians is critical for patients in the emergency department. The aim of this study was to determinate effectiveness of whatsApp usage for communication between physicians.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Adiyaman University Research Hospital

Adıyaman, Central, 02000, Turkey (Türkiye)

About this study

Effective communication between consulting physicians and the emergency physicians is critical for patients in the emergency department. Many hospitals still use outdated pager systems as the foundation for clinical communication between physicians and other health care professionals. But, outdated pager systems contain some problems including long waiting-times for the return of a page, high costs, frequent interruptions, and the inability to identify the location or identity of the caller. This outdated communication technologies in healthcare can place patient safety at risk. Therefore they are no longer seen as an effective communication tool given the obvious advantages of Smart phones. WhatsApp Messenger, which is a messaging program for smart phones, is the most commonly used for communication in at present. As of September 2015, WhatsApp incorporated announced more than 900 million users. This is making it the most globally popular messaging application. WhatsApp Messenger have been started to be used for communication in healthcare. So, this study aims to trial the effect of whatsApp usage for communication between physicians.

Study Design and Setting: A prospective, randomized, double-blind, controlled, single-center, clinical trial was conducted in ED of a tertiary care university hospital with an annual census of approximately 200,000 visits.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients who performed consultation in emergency department.
  • Patients who are consulted to a physician using whatsApp on a regular basis and who is chosen by an assistant blinded to the study.

Exclusion criteria

  • Patients below 18 years of age
  • Missing emergency service consultations
  • Patients with more than one consultation call
  • Consultations which do not determined the arrival duration to emergency service

Treatment and study plan

whatsApp

Other

whatsApp application will be used for consultations.

without whatsApp

Other

whatsApp application will be not used for consultations.

Primary outcomes

  1. arrival duration to emergency department

    Time frame: one month

    Examine consulting Physicians' arrival duration to emergency department will be obtained from consultation hours in whatsApp program.

Secondary outcomes

  1. examine causes of consulting Physicians' arriving late to emergency department from data obtained by questioning of an assistant blinded to the study

    Time frame: one month

Sponsors and collaborators

Lead sponsor

Adiyaman University Research Hospital

Other

Registry information

Official study title

Effectiveness of WhatsApp Messenger Usage and Other Technologises on Communication Between Consulting Physicians and the Emergency Department Staff: Randomised Double-blind Controlled Trial

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Oct 26, 2015
Registry last updated
Mar 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.